Industry Research Reports
Home > Reports > Medical Devices & Consumables > Global Nitinol Thrombectomy Stent Market Outlook, In‑Depth Analysis & Forecast to 2031
Global Nitinol Thrombectomy Stent Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Medical Devices & Consumables
Published Date: 2025-08-05
Pages: 175 Pages
Report ld: 4859116
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
The global Nitinol Thrombectomy Stent market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Nitinol thrombectomy stent is a medical device used for removing blood clots from vessels, primarily made of nitinol alloy. The stent has excellent flexibility and shape memory, allowing it to conform to the vessel's shape. Once deployed inside the vessel, it can capture and remove the clot, commonly used for treating acute ischemic stroke and peripheral vascular diseases.
From a downstream perspective, Hospital accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Nitinol Thrombectomy Stent leading manufacturers including Rapid Medical, Acandis GmbH, Medtronic, Stryker, Johnson & Johnson MedTech, Suzhou Zhongtian Medical, Micro-Port Shentong Medical, Guichuangtongqiao Medical, Xinkainuo Medical, Jianshi Medical, etc., dominate supply; the top five capture approximately % of global revenue, with Rapid Medical leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Nitinol Thrombectomy Stent market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- Rapid Medical
- Acandis GmbH
- Medtronic
- Stryker
- Johnson & Johnson MedTech
- Suzhou Zhongtian Medical
- Micro-Port Shentong Medical
- Guichuangtongqiao Medical
- Xinkainuo Medical
- Jianshi Medical
- Xinwei Medical
- Hemu Biotech
- Sinoshenchang Medical
- Furukawa Techno Material
- Penumbra
- Balt Group
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Diameter 3MM
- Diameter 4MM
- Diameter 6MM
- Other
Segment by Application
- Hospital
- Clinic
- Other
CHAPTER OUTLINE
Chapter 1: Defines the Nitinol Thrombectomy Stent study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Nitinol Thrombectomy Stent: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Nitinol Thrombectomy Stent Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Diameter 3MM
1.2.3 Diameter 4MM
1.2.4 Diameter 6MM
1.2.5 Other
1.3 Market Segmentation by Application
1.3.1 Global Nitinol Thrombectomy Stent Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Nitinol Thrombectomy Stent Revenue Estimates and Forecasts 2020-2031
2.2 Global Nitinol Thrombectomy Stent Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Nitinol Thrombectomy Stent Sales Estimates and Forecasts 2020-2031
2.4 Global Nitinol Thrombectomy Stent Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Nitinol Thrombectomy Stent Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Nitinol Thrombectomy Stent Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Diameter 3MM Market Size by Manufacturers
3.5.2 Diameter 4MM Market Size by Manufacturers
3.5.3 Diameter 6MM Market Size by Manufacturers
3.5.4 Other Market Size by Manufacturers
3.6 Global Nitinol Thrombectomy Stent Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Nitinol Thrombectomy Stent Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Nitinol Thrombectomy Stent Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Nitinol Thrombectomy Stent Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Nitinol Thrombectomy Stent Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Nitinol Thrombectomy Stent Sales and Revenue by Type (2020-2031)
6.4 North America Nitinol Thrombectomy Stent Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Nitinol Thrombectomy Stent Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Nitinol Thrombectomy Stent Sales and Revenue by Type (2020-2031)
7.4 Europe Nitinol Thrombectomy Stent Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Nitinol Thrombectomy Stent Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Nitinol Thrombectomy Stent Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Nitinol Thrombectomy Stent Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Nitinol Thrombectomy Stent Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Nitinol Thrombectomy Stent Sales and Revenue by Type (2020-2031)
9.4 Central and South America Nitinol Thrombectomy Stent Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Nitinol Thrombectomy Stent Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Nitinol Thrombectomy Stent Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Nitinol Thrombectomy Stent Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Nitinol Thrombectomy Stent Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Rapid Medical
11.1.1 Rapid Medical Corporation Information
11.1.2 Rapid Medical Business Overview
11.1.3 Rapid Medical Nitinol Thrombectomy Stent Product Models, Descriptions and Specifications
11.1.4 Rapid Medical Nitinol Thrombectomy Stent Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Rapid Medical Nitinol Thrombectomy Stent Sales by Product in 2024
11.1.6 Rapid Medical Nitinol Thrombectomy Stent Sales by Application in 2024
11.1.7 Rapid Medical Nitinol Thrombectomy Stent Sales by Geographic Area in 2024
11.1.8 Rapid Medical Nitinol Thrombectomy Stent SWOT Analysis
11.1.9 Rapid Medical Recent Developments
11.2 Acandis GmbH
11.2.1 Acandis GmbH Corporation Information
11.2.2 Acandis GmbH Business Overview
11.2.3 Acandis GmbH Nitinol Thrombectomy Stent Product Models, Descriptions and Specifications
11.2.4 Acandis GmbH Nitinol Thrombectomy Stent Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Acandis GmbH Nitinol Thrombectomy Stent Sales by Product in 2024
11.2.6 Acandis GmbH Nitinol Thrombectomy Stent Sales by Application in 2024
11.2.7 Acandis GmbH Nitinol Thrombectomy Stent Sales by Geographic Area in 2024
11.2.8 Acandis GmbH Nitinol Thrombectomy Stent SWOT Analysis
11.2.9 Acandis GmbH Recent Developments
11.3 Medtronic
11.3.1 Medtronic Corporation Information
11.3.2 Medtronic Business Overview
11.3.3 Medtronic Nitinol Thrombectomy Stent Product Models, Descriptions and Specifications
11.3.4 Medtronic Nitinol Thrombectomy Stent Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Medtronic Nitinol Thrombectomy Stent Sales by Product in 2024
11.3.6 Medtronic Nitinol Thrombectomy Stent Sales by Application in 2024
11.3.7 Medtronic Nitinol Thrombectomy Stent Sales by Geographic Area in 2024
11.3.8 Medtronic Nitinol Thrombectomy Stent SWOT Analysis
11.3.9 Medtronic Recent Developments
11.4 Stryker
11.4.1 Stryker Corporation Information
11.4.2 Stryker Business Overview
11.4.3 Stryker Nitinol Thrombectomy Stent Product Models, Descriptions and Specifications
11.4.4 Stryker Nitinol Thrombectomy Stent Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Stryker Nitinol Thrombectomy Stent Sales by Product in 2024
11.4.6 Stryker Nitinol Thrombectomy Stent Sales by Application in 2024
11.4.7 Stryker Nitinol Thrombectomy Stent Sales by Geographic Area in 2024
11.4.8 Stryker Nitinol Thrombectomy Stent SWOT Analysis
11.4.9 Stryker Recent Developments
11.5 Johnson & Johnson MedTech
11.5.1 Johnson & Johnson MedTech Corporation Information
11.5.2 Johnson & Johnson MedTech Business Overview
11.5.3 Johnson & Johnson MedTech Nitinol Thrombectomy Stent Product Models, Descriptions and Specifications
11.5.4 Johnson & Johnson MedTech Nitinol Thrombectomy Stent Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Johnson & Johnson MedTech Nitinol Thrombectomy Stent Sales by Product in 2024
11.5.6 Johnson & Johnson MedTech Nitinol Thrombectomy Stent Sales by Application in 2024
11.5.7 Johnson & Johnson MedTech Nitinol Thrombectomy Stent Sales by Geographic Area in 2024
11.5.8 Johnson & Johnson MedTech Nitinol Thrombectomy Stent SWOT Analysis
11.5.9 Johnson & Johnson MedTech Recent Developments
11.6 Suzhou Zhongtian Medical
11.6.1 Suzhou Zhongtian Medical Corporation Information
11.6.2 Suzhou Zhongtian Medical Business Overview
11.6.3 Suzhou Zhongtian Medical Nitinol Thrombectomy Stent Product Models, Descriptions and Specifications
11.6.4 Suzhou Zhongtian Medical Nitinol Thrombectomy Stent Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Suzhou Zhongtian Medical Recent Developments
11.7 Micro-Port Shentong Medical
11.7.1 Micro-Port Shentong Medical Corporation Information
11.7.2 Micro-Port Shentong Medical Business Overview
11.7.3 Micro-Port Shentong Medical Nitinol Thrombectomy Stent Product Models, Descriptions and Specifications
11.7.4 Micro-Port Shentong Medical Nitinol Thrombectomy Stent Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Micro-Port Shentong Medical Recent Developments
11.8 Guichuangtongqiao Medical
11.8.1 Guichuangtongqiao Medical Corporation Information
11.8.2 Guichuangtongqiao Medical Business Overview
11.8.3 Guichuangtongqiao Medical Nitinol Thrombectomy Stent Product Models, Descriptions and Specifications
11.8.4 Guichuangtongqiao Medical Nitinol Thrombectomy Stent Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Guichuangtongqiao Medical Recent Developments
11.9 Xinkainuo Medical
11.9.1 Xinkainuo Medical Corporation Information
11.9.2 Xinkainuo Medical Business Overview
11.9.3 Xinkainuo Medical Nitinol Thrombectomy Stent Product Models, Descriptions and Specifications
11.9.4 Xinkainuo Medical Nitinol Thrombectomy Stent Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Xinkainuo Medical Recent Developments
11.10 Jianshi Medical
11.10.1 Jianshi Medical Corporation Information
11.10.2 Jianshi Medical Business Overview
11.10.3 Jianshi Medical Nitinol Thrombectomy Stent Product Models, Descriptions and Specifications
11.10.4 Jianshi Medical Nitinol Thrombectomy Stent Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 Jianshi Medical Recent Developments
11.11 Xinwei Medical
11.11.1 Xinwei Medical Corporation Information
11.11.2 Xinwei Medical Business Overview
11.11.3 Xinwei Medical Nitinol Thrombectomy Stent Product Models, Descriptions and Specifications
11.11.4 Xinwei Medical Nitinol Thrombectomy Stent Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 Xinwei Medical Recent Developments
11.12 Hemu Biotech
11.12.1 Hemu Biotech Corporation Information
11.12.2 Hemu Biotech Business Overview
11.12.3 Hemu Biotech Nitinol Thrombectomy Stent Product Models, Descriptions and Specifications
11.12.4 Hemu Biotech Nitinol Thrombectomy Stent Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 Hemu Biotech Recent Developments
11.13 Sinoshenchang Medical
11.13.1 Sinoshenchang Medical Corporation Information
11.13.2 Sinoshenchang Medical Business Overview
11.13.3 Sinoshenchang Medical Nitinol Thrombectomy Stent Product Models, Descriptions and Specifications
11.13.4 Sinoshenchang Medical Nitinol Thrombectomy Stent Sales, Price, Revenue and Gross Margin (2020-2025)
11.13.5 Sinoshenchang Medical Recent Developments
11.14 Furukawa Techno Material
11.14.1 Furukawa Techno Material Corporation Information
11.14.2 Furukawa Techno Material Business Overview
11.14.3 Furukawa Techno Material Nitinol Thrombectomy Stent Product Models, Descriptions and Specifications
11.14.4 Furukawa Techno Material Nitinol Thrombectomy Stent Sales, Price, Revenue and Gross Margin (2020-2025)
11.14.5 Furukawa Techno Material Recent Developments
11.15 Penumbra
11.15.1 Penumbra Corporation Information
11.15.2 Penumbra Business Overview
11.15.3 Penumbra Nitinol Thrombectomy Stent Product Models, Descriptions and Specifications
11.15.4 Penumbra Nitinol Thrombectomy Stent Sales, Price, Revenue and Gross Margin (2020-2025)
11.15.5 Penumbra Recent Developments
11.16 Balt Group
11.16.1 Balt Group Corporation Information
11.16.2 Balt Group Business Overview
11.16.3 Balt Group Nitinol Thrombectomy Stent Product Models, Descriptions and Specifications
11.16.4 Balt Group Nitinol Thrombectomy Stent Sales, Price, Revenue and Gross Margin (2020-2025)
11.16.5 Balt Group Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Nitinol Thrombectomy Stent Industry Chain
12.2 Nitinol Thrombectomy Stent Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Nitinol Thrombectomy Stent Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Nitinol Thrombectomy Stent Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Nitinol Thrombectomy Stent Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Nitinol Thrombectomy Stent Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Nitinol Thrombectomy Stent Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Nitinol Thrombectomy Stent Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Nitinol Thrombectomy Stent Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Nitinol Thrombectomy Stent Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Nitinol Thrombectomy Stent Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Nitinol Thrombectomy Stent Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
Table 7. Global Nitinol Thrombectomy Stent Sales by Region (2020-2025) & (K Units)
Table 8. Global Nitinol Thrombectomy Stent Sales by Region (2026-2031) & (K Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Nitinol Thrombectomy Stent Sales by Manufacturers (2020-2025) & (K Units)
Table 11. Global Nitinol Thrombectomy Stent Sales Share by Manufacturers (2020-2025)
Table 12. Global Nitinol Thrombectomy Stent Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Nitinol Thrombectomy Stent Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Nitinol Thrombectomy Stent by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nitinol Thrombectomy Stent as of 2024)
Table 16. Global Nitinol Thrombectomy Stent Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Nitinol Thrombectomy Stent Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers Nitinol Thrombectomy Stent Manufacturing Base and Headquarters
Table 19. Global Nitinol Thrombectomy Stent Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Nitinol Thrombectomy Stent Sales by Type (2020-2025) & (K Units)
Table 23. Global Nitinol Thrombectomy Stent Sales by Type (2026-2031) & (K Units)
Table 24. Global Nitinol Thrombectomy Stent Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Nitinol Thrombectomy Stent Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Nitinol Thrombectomy Stent ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Nitinol Thrombectomy Stent Sales by Application (2020-2025) & (K Units)
Table 29. Global Nitinol Thrombectomy Stent Sales by Application (2026-2031) & (K Units)
Table 30. Nitinol Thrombectomy Stent High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Nitinol Thrombectomy Stent Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Nitinol Thrombectomy Stent Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Nitinol Thrombectomy Stent ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Nitinol Thrombectomy Stent Growth Accelerators and Market Barriers
Table 37. North America Nitinol Thrombectomy Stent Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Nitinol Thrombectomy Stent Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Nitinol Thrombectomy Stent Growth Accelerators and Market Barriers
Table 40. Europe Nitinol Thrombectomy Stent Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Nitinol Thrombectomy Stent Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Nitinol Thrombectomy Stent Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Nitinol Thrombectomy Stent Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Nitinol Thrombectomy Stent Growth Accelerators and Market Barriers
Table 45. Southeast Asia Nitinol Thrombectomy Stent Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Nitinol Thrombectomy Stent Investment Opportunities and Key Challenges
Table 47. Central and South America Nitinol Thrombectomy Stent Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Nitinol Thrombectomy Stent Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Nitinol Thrombectomy Stent Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Rapid Medical Corporation Information
Table 51. Rapid Medical Description and Major Businesses
Table 52. Rapid Medical Product Models, Descriptions and Specifications
Table 53. Rapid Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. Rapid Medical Sales Value Proportion by Product in 2024
Table 55. Rapid Medical Sales Value Proportion by Application in 2024
Table 56. Rapid Medical Sales Value Proportion by Geographic Area in 2024
Table 57. Rapid Medical Nitinol Thrombectomy Stent SWOT Analysis
Table 58. Rapid Medical Recent Developments
Table 59. Acandis GmbH Corporation Information
Table 60. Acandis GmbH Description and Major Businesses
Table 61. Acandis GmbH Product Models, Descriptions and Specifications
Table 62. Acandis GmbH Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. Acandis GmbH Sales Value Proportion by Product in 2024
Table 64. Acandis GmbH Sales Value Proportion by Application in 2024
Table 65. Acandis GmbH Sales Value Proportion by Geographic Area in 2024
Table 66. Acandis GmbH Nitinol Thrombectomy Stent SWOT Analysis
Table 67. Acandis GmbH Recent Developments
Table 68. Medtronic Corporation Information
Table 69. Medtronic Description and Major Businesses
Table 70. Medtronic Product Models, Descriptions and Specifications
Table 71. Medtronic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. Medtronic Sales Value Proportion by Product in 2024
Table 73. Medtronic Sales Value Proportion by Application in 2024
Table 74. Medtronic Sales Value Proportion by Geographic Area in 2024
Table 75. Medtronic Nitinol Thrombectomy Stent SWOT Analysis
Table 76. Medtronic Recent Developments
Table 77. Stryker Corporation Information
Table 78. Stryker Description and Major Businesses
Table 79. Stryker Product Models, Descriptions and Specifications
Table 80. Stryker Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Stryker Sales Value Proportion by Product in 2024
Table 82. Stryker Sales Value Proportion by Application in 2024
Table 83. Stryker Sales Value Proportion by Geographic Area in 2024
Table 84. Stryker Nitinol Thrombectomy Stent SWOT Analysis
Table 85. Stryker Recent Developments
Table 86. Johnson & Johnson MedTech Corporation Information
Table 87. Johnson & Johnson MedTech Description and Major Businesses
Table 88. Johnson & Johnson MedTech Product Models, Descriptions and Specifications
Table 89. Johnson & Johnson MedTech Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Johnson & Johnson MedTech Sales Value Proportion by Product in 2024
Table 91. Johnson & Johnson MedTech Sales Value Proportion by Application in 2024
Table 92. Johnson & Johnson MedTech Sales Value Proportion by Geographic Area in 2024
Table 93. Johnson & Johnson MedTech Nitinol Thrombectomy Stent SWOT Analysis
Table 94. Johnson & Johnson MedTech Recent Developments
Table 95. Suzhou Zhongtian Medical Corporation Information
Table 96. Suzhou Zhongtian Medical Description and Major Businesses
Table 97. Suzhou Zhongtian Medical Product Models, Descriptions and Specifications
Table 98. Suzhou Zhongtian Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. Suzhou Zhongtian Medical Recent Developments
Table 100. Micro-Port Shentong Medical Corporation Information
Table 101. Micro-Port Shentong Medical Description and Major Businesses
Table 102. Micro-Port Shentong Medical Product Models, Descriptions and Specifications
Table 103. Micro-Port Shentong Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. Micro-Port Shentong Medical Recent Developments
Table 105. Guichuangtongqiao Medical Corporation Information
Table 106. Guichuangtongqiao Medical Description and Major Businesses
Table 107. Guichuangtongqiao Medical Product Models, Descriptions and Specifications
Table 108. Guichuangtongqiao Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 109. Guichuangtongqiao Medical Recent Developments
Table 110. Xinkainuo Medical Corporation Information
Table 111. Xinkainuo Medical Description and Major Businesses
Table 112. Xinkainuo Medical Product Models, Descriptions and Specifications
Table 113. Xinkainuo Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 114. Xinkainuo Medical Recent Developments
Table 115. Jianshi Medical Corporation Information
Table 116. Jianshi Medical Description and Major Businesses
Table 117. Jianshi Medical Product Models, Descriptions and Specifications
Table 118. Jianshi Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 119. Jianshi Medical Recent Developments
Table 120. Xinwei Medical Corporation Information
Table 121. Xinwei Medical Description and Major Businesses
Table 122. Xinwei Medical Product Models, Descriptions and Specifications
Table 123. Xinwei Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 124. Xinwei Medical Recent Developments
Table 125. Hemu Biotech Corporation Information
Table 126. Hemu Biotech Description and Major Businesses
Table 127. Hemu Biotech Product Models, Descriptions and Specifications
Table 128. Hemu Biotech Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 129. Hemu Biotech Recent Developments
Table 130. Sinoshenchang Medical Corporation Information
Table 131. Sinoshenchang Medical Description and Major Businesses
Table 132. Sinoshenchang Medical Product Models, Descriptions and Specifications
Table 133. Sinoshenchang Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 134. Sinoshenchang Medical Recent Developments
Table 135. Furukawa Techno Material Corporation Information
Table 136. Furukawa Techno Material Description and Major Businesses
Table 137. Furukawa Techno Material Product Models, Descriptions and Specifications
Table 138. Furukawa Techno Material Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 139. Furukawa Techno Material Recent Developments
Table 140. Penumbra Corporation Information
Table 141. Penumbra Description and Major Businesses
Table 142. Penumbra Product Models, Descriptions and Specifications
Table 143. Penumbra Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 144. Penumbra Recent Developments
Table 145. Balt Group Corporation Information
Table 146. Balt Group Description and Major Businesses
Table 147. Balt Group Product Models, Descriptions and Specifications
Table 148. Balt Group Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 149. Balt Group Recent Developments
Table 150. Key Raw Materials Distribution
Table 151. Raw Materials Key Suppliers
Table 152. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 153. Milestones in Production Technology Evolution
Table 154. Distributors List
Table 155. Market Trends and Market Evolution
Table 156. Market Drivers and Opportunities
Table 157. Market Challenges, Risks, and Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Nitinol Thrombectomy Stent Product Picture
Figure 2. Global Nitinol Thrombectomy Stent Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Diameter 3MM Product Picture
Figure 4. Diameter 4MM Product Picture
Figure 5. Diameter 6MM Product Picture
Figure 6. Other Product Picture
Figure 7. Global Nitinol Thrombectomy Stent Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Other
Figure 11. Nitinol Thrombectomy Stent Report Years Considered
Figure 12. Global Nitinol Thrombectomy Stent Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Nitinol Thrombectomy Stent Revenue (2020-2031) & (US$ Million)
Figure 14. Global Nitinol Thrombectomy Stent Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 15. Global Nitinol Thrombectomy Stent Revenue Market Share by Region (2020-2031)
Figure 16. Global Nitinol Thrombectomy Stent Sales (2020-2031) & (K Units)
Figure 17. Global Nitinol Thrombectomy Stent Sales (CAGR) by Region (2020-2031) (K Units)
Figure 18. Global Nitinol Thrombectomy Stent Sales Market Share by Region (2020-2031)
Figure 19. Top 5 and Top 10 Manufacturers Nitinol Thrombectomy Stent Sales Volume Market Share in 2024
Figure 20. Global Nitinol Thrombectomy Stent Revenue Market Share Ranking (2024)
Figure 21. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 22. Diameter 3MM Revenue Market Share by Manufacturer in 2024
Figure 23. Diameter 4MM Revenue Market Share by Manufacturer in 2024
Figure 24. Diameter 6MM Revenue Market Share by Manufacturer in 2024
Figure 25. Other Revenue Market Share by Manufacturer in 2024
Figure 26. Global Nitinol Thrombectomy Stent Sales Market Share by Type (2020-2031)
Figure 27. Global Nitinol Thrombectomy Stent Revenue Market Share by Type (2020-2031)
Figure 28. Global Nitinol Thrombectomy Stent Sales Market Share by Application (2020-2031)
Figure 29. Global Nitinol Thrombectomy Stent Revenue Market Share by Application (2020-2031)
Figure 30. North America Nitinol Thrombectomy Stent Sales YoY (2020-2031) & (K Units)
Figure 31. North America Nitinol Thrombectomy Stent Revenue YoY (2020-2031) & (US$ Million)
Figure 32. North America Top 5 Manufacturers Nitinol Thrombectomy Stent Sales Revenue (US$ Million) in 2024
Figure 33. North America Nitinol Thrombectomy Stent Sales Volume (K Units) by Type (2020- 2031)
Figure 34. North America Nitinol Thrombectomy Stent Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 35. North America Nitinol Thrombectomy Stent Sales Volume (K Units) by Application (2020-2031)
Figure 36. North America Nitinol Thrombectomy Stent Sales Revenue (US$ Million) by Application (2020-2031)
Figure 37. US Nitinol Thrombectomy Stent Revenue (2020-2031) & (US$ Million)
Figure 38. Canada Nitinol Thrombectomy Stent Revenue (2020-2031) & (US$ Million)
Figure 39. Mexico Nitinol Thrombectomy Stent Revenue (2020-2031) & (US$ Million)
Figure 40. Europe Nitinol Thrombectomy Stent Sales YoY (2020-2031) & (K Units)
Figure 41. Europe Nitinol Thrombectomy Stent Revenue YoY (2020-2031) & (US$ Million)
Figure 42. Europe Top 5 Manufacturers Nitinol Thrombectomy Stent Sales Revenue (US$ Million) in 2024
Figure 43. Europe Nitinol Thrombectomy Stent Sales Volume (K Units) by Type (2020-2031)
Figure 44. Europe Nitinol Thrombectomy Stent Sales Revenue (US$ Million) by Type (2020-2031)
Figure 45. Europe Nitinol Thrombectomy Stent Sales Volume (K Units) by Application (2020-2031)
Figure 46. Europe Nitinol Thrombectomy Stent Sales Revenue (US$ Million) by Application (2020-2031)
Figure 47. Germany Nitinol Thrombectomy Stent Revenue (2020-2031) & (US$ Million)
Figure 48. France Nitinol Thrombectomy Stent Revenue (2020-2031) & (US$ Million)
Figure 49. U.K. Nitinol Thrombectomy Stent Revenue (2020-2031) & (US$ Million)
Figure 50. Italy Nitinol Thrombectomy Stent Revenue (2020-2031) & (US$ Million)
Figure 51. Russia Nitinol Thrombectomy Stent Revenue (2020-2031) & (US$ Million)
Figure 52. Asia-Pacific Nitinol Thrombectomy Stent Sales YoY (2020-2031) & (K Units)
Figure 53. Asia-Pacific Nitinol Thrombectomy Stent Revenue YoY (2020-2031) & (US$ Million)
Figure 54. Asia-Pacific Top 8 Manufacturers Nitinol Thrombectomy Stent Sales Revenue (US$ Million) in 2024
Figure 55. Asia-Pacific Nitinol Thrombectomy Stent Sales Volume (K Units) by Type (2020- 2031)
Figure 56. Asia-Pacific Nitinol Thrombectomy Stent Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 57. Asia-Pacific Nitinol Thrombectomy Stent Sales Volume (K Units) by Application (2020-2031)
Figure 58. Asia-Pacific Nitinol Thrombectomy Stent Sales Revenue (US$ Million) by Application (2020-2031)
Figure 59. Indonesia Nitinol Thrombectomy Stent Revenue (2020-2031) & (US$ Million)
Figure 60. Japan Nitinol Thrombectomy Stent Revenue (2020-2031) & (US$ Million)
Figure 61. South Korea Nitinol Thrombectomy Stent Revenue (2020-2031) & (US$ Million)
Figure 62. China Taiwan Nitinol Thrombectomy Stent Revenue (2020-2031) & (US$ Million)
Figure 63. India Nitinol Thrombectomy Stent Revenue (2020-2031) & (US$ Million)
Figure 64. Central and South America Nitinol Thrombectomy Stent Sales YoY (2020-2031) & (K Units)
Figure 65. Central and South America Nitinol Thrombectomy Stent Revenue YoY (2020-2031) & (US$ Million)
Figure 66. Central and South America Top 5 Manufacturers Nitinol Thrombectomy Stent Sales Revenue (US$ Million) in 2024
Figure 67. Central and South America Nitinol Thrombectomy Stent Sales Volume (K Units) by Type (2021-2031)
Figure 68. Central and South America Nitinol Thrombectomy Stent Sales Revenue (US$ Million) by Type (2020-2031)
Figure 69. Central and South America Nitinol Thrombectomy Stent Sales Volume (K Units) by Application (2020-2031)
Figure 70. Central and South America Nitinol Thrombectomy Stent Sales Revenue (US$ Million) by Application (2020-2031)
Figure 71. Brazil Nitinol Thrombectomy Stent Revenue (2020-2025) & (US$ Million)
Figure 72. Argentina Nitinol Thrombectomy Stent Revenue (2020-2025) & (US$ Million)
Figure 73. Middle East, and Africa Nitinol Thrombectomy Stent Sales YoY (2020-2031) & (K Units)
Figure 74. Middle East and Africa Nitinol Thrombectomy Stent Revenue YoY (2020-2031) & (US$ Million)
Figure 75. Middle East and Africa Top 5 Manufacturers Nitinol Thrombectomy Stent Sales Revenue (US$ Million) in 2024
Figure 76. Middle East and Africa Nitinol Thrombectomy Stent Sales Volume (K Units) by Type (2021-2031)
Figure 77. South America Nitinol Thrombectomy Stent Sales Revenue (US$ Million) by Type (2020-2031)
Figure 78. Middle East and Africa Nitinol Thrombectomy Stent Sales Volume (K Units) by Application (2020-2031)
Figure 79. Middle East and Africa Nitinol Thrombectomy Stent Sales Revenue (US$ Million) by Application (2020-2031)
Figure 80. GCC Countries Nitinol Thrombectomy Stent Revenue (2020-2025) & (US$ Million)
Figure 81. Turkey Nitinol Thrombectomy Stent Revenue (2020-2025) & (US$ Million)
Figure 82. Egypt Nitinol Thrombectomy Stent Revenue (2020-2025) & (US$ Million)
Figure 83. South Africa Nitinol Thrombectomy Stent Revenue (2020-2025) & (US$ Million)
Figure 84. Nitinol Thrombectomy Stent Industry Chain Mapping
Figure 85. Regional Nitinol Thrombectomy Stent Manufacturing Base Distribution (%)
Figure 86. Global Nitinol Thrombectomy Stent Production Market Share by Region (2020-2031)
Figure 87. Nitinol Thrombectomy Stent Production Process
Figure 88. Regional Nitinol Thrombectomy Stent Production Cost Structure
Figure 89. Channels of Distribution (Direct Vs Distribution)
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Nitinol Thrombectomy Stent market?
The top companies in the global Nitinol Thrombectomy Stent market are Rapid Medical、Acandis GmbH、Medtronic.
Related Reports
Global Nitinol Thrombectomy Stent Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Nitinol Thrombectomy Stent market is projected to grow from US$ 218 million in 2025 to US$ 411 million by 2032, at a CAGR of 9.5% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-26
Pages: 155
USD 4900.00
(Single User License)
Global Nitinol Thrombectomy Stent Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Nitinol Thrombectomy Stent market size was US$ 218 million in 2025 and is forecast to reach a readjusted size of US$ 411 million by 2032 with a CAGR of 9.5% during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 97
USD 4250.00
(Single User License)
Nitinol Thrombectomy Stent- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Nitinol Thrombectomy Stent was estimated to be worth US$ 218 million in 2025 and is projected to reach US$ 411 million, growing at a CAGR of 9.5% from 2026 to 2032.
Published Date: 2026-03-15
Pages: 121
USD 3950.00
(Single User License)
Global Nitinol Thrombectomy Stent Market Research Report 2026
The global Nitinol Thrombectomy Stent market was valued at US$ 218 million in 2025 and is anticipated to reach US$ 411 million by 2032, at a CAGR of 9.5% from 2026 to 2032.
Published Date: 2026-03-15
Pages: 127
USD 2900.00
(Single User License)
Global Nitinol Thrombectomy Stent Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Nitinol Thrombectomy Stent market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 108
USD 4250.00
(Single User License)
Nitinol Thrombectomy Stent - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Nitinol Thrombectomy Stent was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 137
USD 3950.00
(Single User License)
Global Nitinol Thrombectomy Stent Market Research Report 2025
The global market for Nitinol Thrombectomy Stent was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-10
Pages: 100
USD 2900.00
(Single User License)
Global and United States Nitinol Thrombectomy Stent Market Report & Forecast 2024-2030
Nitinol thrombectomy stent is a medical device used for removing blood clots from vessels, primarily made of nitinol alloy. The stent has excellent flexibility and shape memory, allowing it to conform to the vessel's shape. Once deployed inside the vessel, it can capture and remove the clot, commonly used for treating acute ischemic stroke and peripheral vascular diseases.
Published Date: 2024-10-10
Pages: 146
USD 4350.00
(Single User License)
Global Nitinol Thrombectomy Stent Market Insights, Forecast to 2030
Nitinol thrombectomy stent is a medical device used for removing blood clots from vessels, primarily made of nitinol alloy. The stent has excellent flexibility and shape memory, allowing it to conform to the vessel's shape. Once deployed inside the vessel, it can capture and remove the clot, commonly used for treating acute ischemic stroke and peripheral vascular diseases.
Published Date: 2024-10-10
Pages: 182
USD 4900.00
(Single User License)
Nitinol Thrombectomy Stent- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nitinol thrombectomy stent is a medical device used for removing blood clots from vessels, primarily made of nitinol alloy. The stent has excellent flexibility and shape memory, allowing it to conform to the vessel's shape. Once deployed inside the vessel, it can capture and remove the clot, commonly used for treating acute ischemic stroke and peripheral vascular diseases.
Published Date: 2024-10-10
Pages: 140
USD 3950.00
(Single User License)
Global Nitinol Thrombectomy Stent Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Nitinol Thrombectomy Stent market is projected to grow from US$ 218 million in 2025 to US$ 411 million by 2032, at a CAGR of 9.5% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-26
Pages: 155
USD 4900.00 (Single User License)Global Nitinol Thrombectomy Stent Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Nitinol Thrombectomy Stent market size was US$ 218 million in 2025 and is forecast to reach a readjusted size of US$ 411 million by 2032 with a CAGR of 9.5% during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 97
USD 4250.00 (Single User License)Nitinol Thrombectomy Stent- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Nitinol Thrombectomy Stent was estimated to be worth US$ 218 million in 2025 and is projected to reach US$ 411 million, growing at a CAGR of 9.5% from 2026 to 2032.
Published: 2026-03-15
Pages: 121
USD 3950.00 (Single User License)Global Nitinol Thrombectomy Stent Market Research Report 2026
The global Nitinol Thrombectomy Stent market was valued at US$ 218 million in 2025 and is anticipated to reach US$ 411 million by 2032, at a CAGR of 9.5% from 2026 to 2032.
Published: 2026-03-15
Pages: 127
USD 2900.00 (Single User License)Global Nitinol Thrombectomy Stent Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Nitinol Thrombectomy Stent market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 108
USD 4250.00 (Single User License)Nitinol Thrombectomy Stent - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Nitinol Thrombectomy Stent was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 137
USD 3950.00 (Single User License)Global Nitinol Thrombectomy Stent Market Research Report 2025
The global market for Nitinol Thrombectomy Stent was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-10
Pages: 100
USD 2900.00 (Single User License)Global and United States Nitinol Thrombectomy Stent Market Report & Forecast 2024-2030
Nitinol thrombectomy stent is a medical device used for removing blood clots from vessels, primarily made of nitinol alloy. The stent has excellent flexibility and shape memory, allowing it to conform to the vessel's shape. Once deployed inside the vessel, it can capture and remove the clot, commonly used for treating acute ischemic stroke and peripheral vascular diseases.
Published: 2024-10-10
Pages: 146
USD 4350.00 (Single User License)Global Nitinol Thrombectomy Stent Market Insights, Forecast to 2030
Nitinol thrombectomy stent is a medical device used for removing blood clots from vessels, primarily made of nitinol alloy. The stent has excellent flexibility and shape memory, allowing it to conform to the vessel's shape. Once deployed inside the vessel, it can capture and remove the clot, commonly used for treating acute ischemic stroke and peripheral vascular diseases.
Published: 2024-10-10
Pages: 182
USD 4900.00 (Single User License)Nitinol Thrombectomy Stent- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nitinol thrombectomy stent is a medical device used for removing blood clots from vessels, primarily made of nitinol alloy. The stent has excellent flexibility and shape memory, allowing it to conform to the vessel's shape. Once deployed inside the vessel, it can capture and remove the clot, commonly used for treating acute ischemic stroke and peripheral vascular diseases.
Published: 2024-10-10
Pages: 140
USD 3950.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now